Lv1
10 积分 2024-10-06 加入
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment
3天前
已完结
SELECTing Treatments for Cardiovascular Disease — Obesity in the Spotlight
16天前
已完结
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
16天前
已完结
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
19天前
已完结
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings
19天前
已完结
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
19天前
已完结
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
24天前
已完结
CREDENCE: Significant Victory for Diabetic Kidney Disease
1个月前
已完结
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
1个月前
已完结
Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review
1个月前
已完结
皖公网安备34019202002308
